Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An independent observational study to compare the effectiveness of cytisine and nicotine replacement therapy (NRT) as an aid to smoking cessation

Next Previous
Trial Profile

An independent observational study to compare the effectiveness of cytisine and nicotine replacement therapy (NRT) as an aid to smoking cessation

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Sep 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cytisinicline (Primary) ; Nicotine replacement therapy
  • Indications Smoking withdrawal
  • Focus Therapeutic Use

Most Recent Events

  • 24 Sep 2018 New trial record
  • 18 Sep 2018 According to an Achieve Life Sciences media release, data from this trial has been published in the International Journal of Drug Policy (August 2018).
  • 18 Sep 2018 Results presented in the Achieve Life Sciences media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top